[One- or two-stage approach after osteosynthesis failure in proximal femur fracture-a narrative review]

[股骨近端骨折内固定失败后的一期或二期手术治疗——叙述性综述]

阅读:1

Abstract

BACKGROUND: Failure of osteosynthesis following proximal femur fracture represents an increasing challenge in geriatric traumatology. In these cases, conversion total hip arthroplasty (cTHA) is often required. It remains unclear whether a single-stage or a two-stage approach is superior in terms of infection risk and clinical outcomes. METHODS: A systematic literature search was conducted in PubMed for the period 1995-2025. Included were original articles, systematic reviews, and meta-analyses investigating single-stage or two-stage procedures following osteosynthesis failure of the proximal femur. Case reports, editorials, and studies unrelated to hip arthroplasty were excluded. A total of 17 publications were included in the analysis. Based on the findings, a clinical decision-making algorithm for treatment planning was developed in our own clinic. RESULTS: The available evidence is predominantly based on retrospective studies with small sample sizes. Reported infection rates after cTHA vary widely between studies (0-8.6%). Some studies indicate advantages of the two-stage approach in terms of infection control, while others report comparable outcomes for both strategies. Positive microbiological findings despite the absence of clinical signs of infection are common, but their clinical relevance remains unclear. CONCLUSION: Current evidence does not allow a definitive recommendation in favor of either a single-stage or two-stage approach. Individual risk stratification, considering clinical, laboratory, and radiological parameters, is crucial. The clinical algorithm presented provides a practical approach for decision-making. Prospective multicenter studies are needed to derive robust recommendations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。